8.13.21
6 min. read

Prescription Digital Therapeutic Pipeline updates.

Issue 114

Welcome back to E&O Fridays, a paying subscribers-only weekly newsletter focused on the world of digital pharma products and FDA-regulated digital health.

 E&O Fridays.

Here's what's happening this week in the world of pharma digital

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×
8.11.21
6 min. read

Virgin Pulse DTx bundle pricing. Red Bull’s stack

Issue 019

Welcome back to E&O Wednesdays, the enrollment-focused digital health newsletter from Exits & Outcomes -- for paying subscribers only. This every-other-Wednesday issue digs into digital health companies that sell to self-insured employers

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×
8.09.21
3 min. read

Seven quiet health tech funding deals. Puzzle answer

Issue 036

Welcome back to E&O Mondays, the free newsletter from Exits & Outcomes that features health tech puzzles and trivia, new and under-the-radar funding news, paid content teasers and other digital health odds and ends.

 E&O Mondays.

In this issue:

  • Seven under-the-radar or not-yet-reported health tech funding deals.
  • The long-awaited answer to last week’s Health Tech Rebus Puzzle along with a few readers who got it right…
  • But wait: If this was forwarded your way, why not sign up as a paying subscriber to E&O by clicking right here…

 

Seven secret (or under-reported) health tech funding deals from the past week

Instead of rehashing the dozens of funding deals you’ve already read elsewhere, I focused this week on a number of deals that you likely have not yet read about. (These are all first in E&O — as far as I can Google.)

* Please note: These rounds are unannounced so the full amount the company raises as part of its current round may be higher than the numbers below.

  • $17.7 million – Homecare [DOT] com – “HomeCare [DOT] com provides technology and tools to help families and Caregivers connect with each other.” Site
  • $8.7 million – Asimily – This company offers connected medical device management software to health systems. Site
  • $5.3 million – Reimagine Care – This one is tough to cut through, but to give you a vague sense of what they do: Reimagine “provides technology-enabled services to support community oncologists and healthcare systems in delivering high-quality, more affordable, patient-centric cancer care.” And the company aims “to become the leading national network for the delivery of value-based oncology care” Site
  • $4 million – Courier Health – This news isn’t just stealthy the whole company is still mostly quiet. (For example, the two founders both list themselves at a stealth startup on LinkedIn instead of naming Courier.) The website has a few more hints about the product offerings than the company’s tagline: “The next generation of Patient Engagement for Life Sciences.” Site
  • $1.8 million in debt and other options – Hygieia – This company offers a diabetes app called d-Nav. “The d-Nav Program was created to improve and simplify insulin treatment to make a difference and help more people who are on insulin therapy succeed. The d-Nav program uses an FDA-cleared app to identify glucose patterns and automatically recommend an insulin dose each time the patient injects.” Site
  • $570,000 in equity, options, and other securities – YUR Fitness – “Fitness tracking across any virtual reality game… YUR uses machine learning to analyze movement from both controllers and headsets as well as your biometric profile to give you tailor-made fitness metrics. YUR keeps the notion of a workout alive while you are within any game and it is running in the background. A workout can temporarily be saved offline and will later be uploaded to our servers if you, for example, want to use VR tracked by YUR offline.” Site
  • $100,000 added to its now $2.25 million raise – BetterYou – This isn’t the first time BetterYou has added another $100,000 to this round. “BetterYou is an AI companion that helps you achieve your goals. To date, we’ve helped thousands of people get an extra 30 minutes of sleep each night, improve their talk time with friends by 10 minutes each day, or get another workout in every week.” Site

Health Tech Rebus Answer

Here are four (of the many) very quick-witted E&O readers who sent in the correct answer to last week’s Rebus puzzle:

  • Ushma Baros, NHS Partnerships, Big Health
  • Dena Mendelsohn, Head of Compliance and Privacy, HumanFirst
  • Lisa Suennen, Lead, Digital & Technology business and Lead, Manatt Ventures (Find her on LinkedIn here)
  • Robert Loudon, Associate Director Market Research, Optum

The answer to last week’s puzzle: “For entertainment purposes only”

In the early years of mobile medical apps, this was a commonly used caveat in app store descriptions. App makers were unsure of which apps crossed the line into FDA’s regulatory purview, so they described their blood pressure management apps as “for entertainment purposes only”. These thrilling events led many digital health keynoters to describe digital health as “The Wild West”.

ICYMI — Last week’s Rebus puzzle is below.

Here’s how to play: This kind of puzzle is called a Rebus. Write down or think of the word for what’s pictured in each box as a starting point. Then swap letters (if you see =), or remove letters (when you see -), or add letters (when you see +) at the beginning, middle, or end of the words as noted. Then sound it out.

Hint: When a mobile medical app includes this disclaimer in its AppStore description, scroll on…

That’s a wrap on E&O Mondays 036.
article end logo
×
8.06.21
8 min. read

AI billing codes. Oura and the FDA. Trial updates.

Issue 113

Welcome back to E&O Fridays, a paying subscribers-only weekly newsletter focused on the world of digital pharma products and FDA-regulated digital health.

 E&O Fridays.

Here's what's happening this week in the world of pharma digital

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×
8.02.21
3 min. read

Nine secret health tech funding deals. New puzzle

Issue 035

Welcome back to E&O Mondays, the free newsletter from Exits & Outcomes that features health tech puzzles and trivia, new and under-the-radar funding news, paid content teasers and other digital health odds and ends.

 E&O Mondays.

In this issue:

  • Nine under-the-radar or not-yet-reported health tech funding deals.
  • A brand new Health Tech Rebus Puzzle…
  • But wait: If this was forwarded your way, why not sign up as a paying subscriber to E&O by clicking right here…

 

Nine secret (or under-reported) health tech funding deals from the past two weeks

Instead of rehashing the dozens of funding deals you’ve already read elsewhere, I focused this week on a number of deals that you likely have not yet read about. (These are all first in E&O — as far as I can Google.)

  • $25.7 million in equity and other securities – Meru Health – This news is likely to break soon if it hasn’t by the time this newsletter goes out. “Meru Health is an online healthcare provider that offers an evidence-based program to reduce anxiety, depression, and burnout.” Site
  • $19.9 million – Verifiable – Credentialing as a service: “A modern provider data engine delivering real-time verifications and powerful automation to simplify credentialing and provider network management.” Site
  • $4.3 million – Monitored Therapeutics – “Monitored Therapeutics Inc. (MTI) is Respiratory Telehealthcare Company focused on COPD, Asthma, Lung Transplant, and Cystic Fibrosis with four proprietary products – GoSpiro Home Spirometer, GoHome Patient Health Monitor, GoClinic, GoECG and the MTI CarePortal.” Site
  • $2.1 million – KinoTek – “KinoTek is a vertically integrated movement analysis software company. Move.ly, the company’s flagship software product, captures objective movement data that informs clinicians, educates patients and improves quality of care.” Site
  • $1.9 million – Strados Labs – Strados is a respiratory-focused digital health startup that recently secured FDA clearance for its first device, RESP. Here’s more on RESP from the company’s clearance announcement in December: “The RESP system has been used in clinical trials to help researchers quantify changes in lung sounds over time to compare against treatments, patient-reported outcomes, and other vital signs.” Site
  • $1.8 million – Hank AI – Hank AI is focused on automating work for medical coders – “Hank is a cognitive automation platform that combines traditional machine learning with crowdsourced knowledge to automate repetitive decision-making tasks.” Site
  • $495,000 – LifeGait – The company was formed “to leverage the Internet of Things, big data and its patented gait technology to provide health and safety products to the mass market” and its first commercial application is SportsGait, which aims to diagnose concussions. Site
  • $405,000 – WalkWise – This company makes a device that attaches to walkers to turn them into remote monitoring devices. “Compliance is a non-issue by eliminating the need for daily action, a smartphone, or a wearable. No other technology addresses walker use compliance as a method for preventing falls, despite scientific evidence of the link. Smartwatches simply do not work for walker users, as their wrists do not move while ambulating.” Site
  • $200,000 – VelloHealth – Newish startup from the former CEO of LiveProcess, which also built collaborative software for hospital teams, Nathaniel Weiss. “The VelloHealth Collaboration Platform is an integrated mobile and laptop/desktop solution that helps [serious mental illnesses] care teams better collaborate to provide optimal treatment.” Site

Health Tech Rebus Question

Here’s this week’s Rebus puzzle.

Here’s how to play: This kind of puzzle is called a Rebus. Write down or think of the word for what’s pictured in each box as a starting point. Then swap letters (if you see =), or remove letters (when you see -), or add letters (when you see +) at the beginning, middle, or end of the words as noted. Then sound it out.

Hint: When a mobile medical app includes this disclaimer in its AppStore description, scroll on…

That’s a wrap on E&O Mondays 035.
article end logo
×
7.30.21
5 min. read

AMA considers more remote therapeutic codes. Trial updates.

Issue 112

Welcome back to E&O Fridays, a paying subscribers-only weekly newsletter focused on the world of digital pharma products and FDA-regulated digital health.

 E&O Fridays.

Welcome back to E&O Fridays, a paying subscribers-only weekly

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×
7.28.21
6 min. read

Hinge pricing. Amwell M&A. Novartis stack

Issue 018

Welcome back to E&O Wednesdays, the enrollment-focused digital health newsletter from Exits & Outcomes -- for paying subscribers only. This every-other-Wednesday issue digs into digital health companies that sell to self-insured employers

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×
7.23.21
8 min. read

Pear’s past revenue. Happify Ensemble. Facebook SaMD

Issue 111

Welcome back to E&O Fridays, a paying subscribers-only weekly newsletter focused on the world of digital pharma products and FDA-regulated digital health.

 E&O Fridays.

Here's what's happening this week in the world of pharma digital

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×
7.19.21
5 min. read

10 secret health tech funding deals. Puzzle, trivia answers

Issue 034
Digital health research from Brian Dolan

Welcome back to E&O Mondays, the free newsletter from Exits & Outcomes that features health tech puzzles and trivia, new and under-the-radar funding news, paid content teasers and other digital health odds and ends.

 E&O Mondays.

In this issue:

  • Ten under-the-radar or not-yet-reported health tech funding deals.
  • The long-awaited answer to last week’s Health Tech Rebus Puzzle along with the answer to last week’s bonus trivia question…
  • But wait: Are you ready? If this was forwarded your way, why not sign up as a paying subscriber to E&O by clicking right here…

Ten secret (or under-reported) health tech funding deals from the past week

Instead of rehashing the dozens of funding deals you’ve already read elsewhere, I focused this week on a number of deals that you likely have not yet read about. (These are all first in E&O — as far as I can Google.)

$87.6 million – Eight Sleep – The DTC sleep fitness startup, which apparently once went by the name Morphy, did announce a long list of new investors last month as part of a strategic round of funding, but — as far as I can tell — they never disclosed the dollar amount raised. According to a recent SEC filing, Eight Sleep raised $87.6 million. Its last disclosed raise was a $40 million one back in 2019.

“Eight Sleep is a sleep fitness company whose … technology regulates temperature and analyzes heart respiratory rates, movement, and sleep phases to monitor sleep quality. That data is sent to the company’s app, which analyzes the information and then offers suggestions to improve a user’s sleep fitness.” Site

$3.5 million in options, warrants, and other securities – Capital Rx – The company recently raised $50 million in February, but it also just filed this $3.5 million in options or warrants. Here’s what they do:

“Capital Rx’s enterprise pharmacy platform, JUDI, digitally links providers, patients, pharmacies, and plans… By establishing a competitive marketplace through its Clearinghouse Model, Capital Rx unlocks the pharmacy supply chain to ensure patients receive seamless access to medication at the lowest price.”

$3 million in debt – Yes Health, which raised a $6 million Series A back in the spring of 2020, raised $3 million in debt, according to a recent filing. The company self-drescribes as a “fully CDC-recognized, all-mobile diabetes prevention program with in-the-moment coaching.” Site

$2.3 million in equity and other securities – Wellview – Here’s what this Tennessee-based startup does:

“Wellview is a digital health and virtual care company delivering preventive and chronic condition management care based on consumer behaviors. Wellview’s proprietary, consumer-centric technology application captures data and builds a member’s Care Profile used to drive industry-leading engagement with Wellview’s Care Team, a network of integrated clinical and behavioral health experts.” Site

$2 million – Best Shot Care AKA Fertility Rescripted – The security filing describes the raise as equity but it also includes the conversion of outstanding indebtedness. Here’s what Best Shot Care offers fertility patients and their care teams: “A patient engagement app, clinic dashboard and supportive micro-communities led by experts.” Site

$450,000 – CareTeam is a direct primary care provider that powers on-site clinics and virtual services for employers. It offers: “primary & urgent care services, pharmacy & lab services, chronic disease management, [and] health & wellness coaching.” Site

$305,000 in debt, options, and other securities – Rimidi is a remote monitoring focused digital health company:

“Rimidi enables clinicians to remotely monitor their patients’ blood pressure, blood glucose levels, weight and more, and virtually send encouragement or treatment adjustments when necessary.” Site

$300,000 in debt and other options – Medaica is a quiet startup that has a placeholder page for a website right now. They appear to be focused on connected medical devices and will probably try to build on the current video visit-powered telemedicine model today with things like digital stethoscopes, for example. Unclear if they are selling kits with digital medical devices made by others or if they aim to manufacture the devices themselves. Site

$260,000 in equity and simple agreements for future equity – Thrive365 is focused on nutrition and diabetes:

“Thrive365 is … [a] patented nutritional meal scoring platform proven to benefit individuals living with Type 2 Diabetes and Pre-Diabetes. Our proprietary platform combines the best of nutritional science, world-class technologies and Win the Day health coaching.” Site

$250,000 in other securities – Healthrageous – Healthrageous, one of the original employer-focused digital health companies is back? Sort of. After Humana acquired its assets in 2013, I thought that was the last we’d hear about Healthrageous, but its former CEO Rick Lee has apparently resurrected the brand as a health-focused meal delivery company. The company may have a broader focus on non-medical care as a recent trademark filing indicates:

“Virtual and in-home support services, namely, health and care management services in the nature of the coordination of necessary services and personal care for non-medical virtual, in person, and in-home personal care services for assisting with daily living activities.”

Health Tech Rebus Answer (Trivia answer too)

Here’s the answer to last Monday’s Health Tech Rebus issue:

“We do not have any competitors”

Many E&O readers admitted they, indeed, have uttered this phrase out loud. Next time someone asks, I’m going to try it out too.

Surprisingly, no one got the bonus trivia question, which was: The CEO of which digital health company was on the team that discovered the Higgs boson particle (the “God Particle) back in 2012? 

The answer: Natural Cycles.

Its CEO and Co-founder Elina Berglund explains the connection in her Linkedin profile: “Elina Berglund is the CEO and co-founder of Natural Cycles – the world’s first, and only, app to be certified as a contraception both in Europe and in the US. She was part of the team that discovered the Higgs boson at the CERN, which led to the Nobel Prize in physics in 2013. Following this success, Elina was looking for an effective natural contraceptive and applied her skills from particle physics to create an algorithm that could accurately pinpoint when a woman is fertile. Elina’s mission is to pioneer women’s health with research and passion – by empowering every woman with the knowledge she needs to be in charge of her health.”

Once again… ICYMI: Last week’s puzzle, hint, (along with directions for how to play) are all included below:

Here’s how to play: This kind of puzzle is called a Rebus. Write down or think of the word for what’s pictured in each box as a starting point. Then swap letters (if you see =), or remove letters (when you see -), or add letters (when you see +) at the beginning, middle, or end of the words as noted. Then sound it out.

Hint: This is what some entrepreneurs tell journalists in response to a common interview question.

That’s a wrap on E&O Mondays 034.
article end logo
×
7.16.21
7 min. read

CMS proposes remote therapeutic monitoring reimbursement

Issue 110
Digital health research from Brian Dolan

Welcome back to E&O Fridays, a paying subscribers-only weekly newsletter focused on the world of digital pharma products and FDA-regulated digital health.

 E&O Fridays.

Here's what's happening

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×